Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 439 word(s) 439 2020-12-15 07:53:58

Video Upload Options

Do you have a full video?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Li, V. FXN Gene. Encyclopedia. Available online: https://encyclopedia.pub/entry/5604 (accessed on 17 April 2024).
Li V. FXN Gene. Encyclopedia. Available at: https://encyclopedia.pub/entry/5604. Accessed April 17, 2024.
Li, Vivi. "FXN Gene" Encyclopedia, https://encyclopedia.pub/entry/5604 (accessed April 17, 2024).
Li, V. (2020, December 25). FXN Gene. In Encyclopedia. https://encyclopedia.pub/entry/5604
Li, Vivi. "FXN Gene." Encyclopedia. Web. 25 December, 2020.
FXN Gene
Edit

Frataxin

genes

1. Normal Function

The FXN gene provides instructions for making a protein called frataxin. This protein is found in cells throughout the body, with the highest levels in the heart, spinal cord, liver, pancreas, and muscles used for voluntary movement (skeletal muscles). Within cells, frataxin is found in energy-producing structures called mitochondria. Although its function is not fully understood, frataxin appears to help assemble clusters of iron and sulfur molecules that are critical for the function of many proteins, including those needed for energy production.

One region of the FXN gene contains a segment of DNA known as a GAA trinucleotide repeat. This segment is made up of a series of three DNA building blocks (one guanine and two adenines) that appear multiple times in a row. In most people, the number of GAA repeats in the FXN gene is fewer than 12 (referred to as short normal). Sometimes, however, the GAA segment is repeated 12 to 33 times (referred to as long normal).

2. Health Conditions Related to Genetic Changes

2.1 Friedreich Ataxia

Friedreich ataxia results from an increased number of copies (expansion) of the GAA trinucleotide repeat in the FXN gene. In people with this condition, the GAA segment is abnormally repeated 66 to more than 1,000 times. The length of the GAA trinucleotide repeat appears to be related to the age at which the symptoms of Friedreich ataxia appear. People with GAA segments repeated fewer than 300 times tend to have a later appearance of symptoms (after age 25) than those with larger GAA trinucleotide repeats.

Most individuals with Friedreich ataxia have the expanded GAA trinucleotide repeat in both copies of the FXN gene. About 2 percent of people with this condition have an expanded GAA trinucleotide repeat in one copy of the FXN gene and a different kind of mutation in the other copy of the gene. In most of these cases, the other mutation changes a single DNA building block (nucleotide) within the FXN gene.

It is not fully understood how FXN gene mutations cause Friedreich ataxia. Mutations in this gene disrupt production of frataxin, greatly reducing the amount of this protein in cells. A shortage of frataxin appears to decrease the activity of proteins that contain iron-sulfur clusters, which could impair the production of energy in mitochondria. Cells with insufficient amounts of frataxin are also particularly sensitive to reactive molecules (free radicals) that can damage and destroy cells. Cells in the brain, spinal cord, and muscles that are damaged or have inadequate energy supplies may not function properly, leading to the signs and symptoms of Friedreich ataxia.

3. Other Names for This Gene

  • CyaY

  • FA

  • FARR

  • FRDA

  • FRDA_HUMAN

  • Friedreich ataxia

  • MGC57199

  • X25

References

  1. Adinolfi S, Trifuoggi M, Politou AS, Martin S, Pastore A. A structuralapproach to understanding the iron-binding properties of phylogeneticallydifferent frataxins. Hum Mol Genet. 2002 Aug 1;11(16):1865-77.
  2. Bidichandani SI, Delatycki MB. Friedreich Ataxia. 1998 Dec 18 [updated 2017Jun 1]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K,Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University ofWashington, Seattle; 1993-2020. Available fromhttp://www.ncbi.nlm.nih.gov/books/NBK1281/
  3. Castaldo I, Pinelli M, Monticelli A, Acquaviva F, Giacchetti M, Filla A,Sacchetti S, Keller S, Avvedimento VE, Chiariotti L, Cocozza S. DNA methylationin intron 1 of the frataxin gene is related to GAA repeat length and age of onsetin Friedreich ataxia patients. J Med Genet. 2008 Dec;45(12):808-12. doi:10.1136/jmg.2008.058594.
  4. Correia AR, Adinolfi S, Pastore A, Gomes CM. Conformational stability of humanfrataxin and effect of Friedreich's ataxia-related mutations on protein folding. Biochem J. 2006 Sep 15;398(3):605-11.
  5. Hebert MD. Targeting the gene in Friedreich ataxia. Biochimie. 2008Aug;90(8):1131-9. doi: 10.1016/j.biochi.2007.12.005.
  6. Pandolfo M, Pastore A. The pathogenesis of Friedreich ataxia and the structureand function of frataxin. J Neurol. 2009 Mar;256 Suppl 1:9-17. doi:10.1007/s00415-009-1003-2. Review.
  7. Pandolfo M. Friedreich ataxia. Arch Neurol. 2008 Oct;65(10):1296-303. doi:10.1001/archneur.65.10.1296. Review.
  8. Seznec H, Simon D, Bouton C, Reutenauer L, Hertzog A, Golik P, Procaccio V,Patel M, Drapier JC, Koenig M, Puccio H. Friedreich ataxia: the oxidative stress paradox. Hum Mol Genet. 2005 Feb 15;14(4):463-74.
  9. Stehling O, Elsässer HP, Brückel B, Mühlenhoff U, Lill R. Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Hum Mol Genet.2004 Dec 1;13(23):3007-15.
More
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 346
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 25 Dec 2020
1000/1000